Skip to main content
Top
Published in: Rheumatology International 4/2019

01-04-2019 | Osteoarthrosis | Public Health

Disability due to rheumatic diseases in the city of Junín, Argentina

Authors: Nauan Fara, Orlando Recchia, Gabriel Sequeira, Karina Sanchez

Published in: Rheumatology International | Issue 4/2019

Login to get access

Abstract

The aim of the study is to analyze the characteristics of patients with rheumatic diseases applying for a Disability Certificate (DC). Every application for DC filed by patients of 16 years of age and older in the Health Secretariat of Junin, between 2012 and 2016, was analyzed regarding age, gender, rheumatic disease as the cause of disability, employment status, and health insurance coverage. Applications were examined as per two elements: inflammatory articular or systemic disease (IASD) versus degenerative diseases, regional or generalized pain syndromes (non-IASD). Based on the DCs accepted, a Disability Prevalence Rate (DPR) was estimated and the most common causes of disability were determined. Out of 400 applications, 68% belonged to women; applicants’ median age was 61 years, only 27% were working, 42% were for DC renewal, and 46% were IASD. Overall, 83% of the applications submitted were accepted. Those patients with accepted DC applications were older (median age 62 vs 55; p < 0.001), had health insurance coverage (90% vs 65%; p <0.001), were applying for DC renewal (49% vs 12%; p < 0.001) and more frequently presented a IASD (52% vs 17%; p < 0.001). 48% of accepted DC applications had osteoarthritis (OA), 36% rheumatoid arthritis (RA), 6% psoriatic arthritis (PsA), 5% systemic lupus erythematosus (SLE) and 2% ankylosing spondylitis (AS). The DPR was 0.5%. Overall, the accepted applications for DC belong to older patients with health insurance coverage, who were submitting an application for DC renewal and suffer from a IASD. OA, RA, PsA, SLE and AS were the five most common causes of disability.
Literature
2.
go back to reference Cardiel P, Riedemann (2006) Epidemiologia de las enfermedades reumáticas. In: Tratado Hispanamericano de Reumatologia. Alarcon Segovia-Molina Eds. 1st Edition. Bogota, pp 121–129 Cardiel P, Riedemann (2006) Epidemiologia de las enfermedades reumáticas. In: Tratado Hispanamericano de Reumatologia. Alarcon Segovia-Molina Eds. 1st Edition. Bogota, pp 121–129
5.
go back to reference Servicio Nacional de Rehabilitación, Ministerio de Salud (2015) Anuario Estadístico Nacional sobre Discapacidad. Anexo. Caracterización de la Población con Discapacidad con certificado único de discapacidad emitido durante el año 2015 según Provincia de residencia. https://www.snr.gob.ar/datos-estadisticos/. Accessed 30 Nov 2018 Servicio Nacional de Rehabilitación, Ministerio de Salud (2015) Anuario Estadístico Nacional sobre Discapacidad. Anexo. Caracterización de la Población con Discapacidad con certificado único de discapacidad emitido durante el año 2015 según Provincia de residencia. https://​www.​snr.​gob.​ar/​datos-estadisticos/​. Accessed 30 Nov 2018
7.
go back to reference Briggs AM, Woolf AD, Dreinhöfer K, Homb N, Hoy D, Kopansky-Giles D et al (2018) Reducing the global burden of musculoskeletal conditions. Bull World Health Organ 96:366–368CrossRefPubMedPubMedCentral Briggs AM, Woolf AD, Dreinhöfer K, Homb N, Hoy D, Kopansky-Giles D et al (2018) Reducing the global burden of musculoskeletal conditions. Bull World Health Organ 96:366–368CrossRefPubMedPubMedCentral
8.
go back to reference WHO Scientific Group (2003) The Burden of Musculoskeletal Conditions at the start of the new Millenium. World Health Organ Tech Rep Ser 919: i–x, 1–218 (back cover) WHO Scientific Group (2003) The Burden of Musculoskeletal Conditions at the start of the new Millenium. World Health Organ Tech Rep Ser 919: i–x, 1–218 (back cover)
10.
go back to reference Baker K, Pope J (2009) Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology 48:281–284CrossRefPubMed Baker K, Pope J (2009) Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology 48:281–284CrossRefPubMed
11.
go back to reference Pisoni C, Muñoz S, Tamborenea M, Garcia M, Curti A, Cappuccio A et al (2018) Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease-related factors. Int J Rheum Dis 21(11):2019–2027CrossRefPubMed Pisoni C, Muñoz S, Tamborenea M, Garcia M, Curti A, Cappuccio A et al (2018) Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease-related factors. Int J Rheum Dis 21(11):2019–2027CrossRefPubMed
14.
go back to reference Mau W, Listing J, Huscher D, Ziedler H.Zink A (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 32(4):721–728PubMed Mau W, Listing J, Huscher D, Ziedler H.Zink A (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 32(4):721–728PubMed
Metadata
Title
Disability due to rheumatic diseases in the city of Junín, Argentina
Authors
Nauan Fara
Orlando Recchia
Gabriel Sequeira
Karina Sanchez
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 4/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04260-5

Other articles of this Issue 4/2019

Rheumatology International 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.